Author

E. R. Henry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:Bayesian inference· 1 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Allison· 1 shared A. K. Chatterjee· 1 shared A. K. Conrey· 1 shared A. R. Fisher· 1 shared B. Iova· 1 shared B. Metaferia· 1 shared C. J. Fraser· 1 shared D. F. Gao· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEvolutionary Biology

A. Allison

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A large nuclear and mitochondrial sequence dataset for phylogenetic analysis of the hyperdiverse Asterophryinae frogs of the New Guinea region with data on lifestyle, GPS coordinates, elevation, and multispecies communities with accompanying code

E. C. Hill, M. Jarman, C. J. Fraser, D. F. Gao, E. R. Henry, A. R. Fisher, B. Iova, A. Allison, M. A. Butler

bioRxiv · Sep 15, 2022 · PreprintEvolutionary Biology

Phenotypic screening of the ReFrame Drug Repurposing Library to discover new drugs for treating sickle cell disease

B. Metaferia, T. Cellmer, E. B. Dunkerlberger, Q. Li, E. R. Henry, J. Hofrichter, D. Staton, M. M. Hsieh, A. K. Conrey, J. F. Tisdale, A. K. Chatterjee, S. L. Thein, W. A. Eaton

This paper screens a drug repurposing library to identify compounds that inhibit sickling in sickle cell disease, finding 106 potential anti-sickling drugs with 21 predicted to be viable oral therapies.

bioRxiv · Jun 23, 2022Pharmacology & Toxicology